BirminghamLive: Facebook bans tattooist’s nipple mastectomy photos. “A tattooist who offers life-like nipple reconstruction tattoos for women who have undergone mastectomies says photos of her work have been removed by Facebook. In a bid to spread the word as to what she can do to help others, Kerry [Irvine] has posted photographs of tattooed nipples on Facebook and Instagram. But she said some of the pictures were removed, her page has been suspended a number of times and she has been blocked out of her account for displaying sexual content.” Facebook has restored the account, but this is one more argument against Facebook policing its own content.
New York University: Combination of Artificial Intelligence & Radiologists More Accurately Identified Breast Cancer. “An artificial intelligence (AI) tool—trained on roughly a million screening mammography images—has identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists.”
University of California San Francisco: Chemical Exposure Web Tool Defines Risks Faced by Millions of California Women. “The tool, which was developed by researchers at UC San Francisco and the California Department of Public Health’s Occupational Health Branch, is part of an ongoing study focused on understanding potential breast cancer risks related to workplace chemical exposures. Users can search the database by ethnicity/race, age, and occupation to see risk information on more than a thousand chemicals, sorted into 24 chemical groups, as well as which chemicals are likely to be present in various occupations.”
National Cancer Institute: BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk. “A global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The BRCA Exchange was created through the BRCA Challenge, a long-term demonstration project initiated by the Global Alliance for Genomics and Health (GA4GH) to enhance sharing of BRCA1 and BRCA2 data. The resource, available through a website and a new smartphone appExit Disclaimer, allows clinicians to review expert classifications of variants in these major cancer predisposition genes as part of their individual assessment of complex questions related to cancer prevention, screening, and intervention for high-risk patients.”
EurekAlert: Deep learning can distinguish recalled-benign mammograms from malignant and negative images . “An artificial intelligence (AI) approach based on deep learning convolutional neural network (CNN) could identify nuanced mammographic imaging features specific for recalled but benign (false-positive) mammograms and distinguish such mammograms from those identified as malignant or negative.”
The Plastic Surgery Foundation: NBIR Now Open Register Today. “The Plastic Surgery Foundation has collaborated with the FDA and breast implant device manufacturers to develop the National Breast Implant Registry (NBIR) to strengthen the post-marketing surveillance infrastructure for current and future breast implant devices. The NBIR is a prospective, non-interventional, population-based, outcomes and safety surveillance registry and quality improvement initiative. The NBIR collects clinical, procedural and outcomes data at the time of operation and any subsequent reoperations for all US patients receiving breast implants. Plastic Surgeons that enter data into the NBIR will be able to compare their practice performance and outcomes to the registry aggregate.”
New York Times: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals. “One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet.”